36.1
Galmed Pharmaceuticals Ltd.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
14.7
FY23:
13.2
FY24:
16.1
FY25:
18.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.55
FY22:
1.84
FY23:
3.39
FY24:
2.38
FY25:
0
Total assets
Change from FY21 to FY25
millions USD
FY21:
36.6
FY22:
16.6
FY23:
16.6
FY24:
18.5
FY25:
18.6
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.88
FY22:
3.09
FY23:
2.75
FY24:
2.17
FY25:
2.85
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.23
FY22:
0.04
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
30.5
FY22:
13.4
FY23:
13.9
FY24:
16.3
FY25:
15.8
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
36.6
FY22:
16.6
FY23:
16.6
FY24:
18.5
FY25:
18.6
All amounts in millions USD